K

Kernal Biologics

Develops onco-selective mRNA therapeutics

Director – LNP Formulation

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USANo salary listedIn-person

About the Job

Requirements

  • A PhD in chemical engineering, organic chemistry, or a related field is required.
  • Eight to ten years of hands-on experience with lipid nanoparticle systems for mRNA and/or siRNA delivery is required.
  • Experience with targeted lipid nanoparticles and conjugation of biomaterials is required.
  • Experience with analytical techniques for lipid nanoparticles is required, including high-performance liquid chromatography/ultra-performance liquid chromatography, liquid chromatography-mass spectrometry, dynamic light scattering, ultraviolet-visible spectroscopy, fluorescence spectrophotometry, Ribogreen assay, gel electrophoresis, capillary electrophoresis, and flow cytometry, including CytoFLEX nano and NanoFCM.
  • Excellent oral and written communication skills are required.
  • Excellent electronic lab notebook record-keeping skills are required.
  • A startup mindset, including innovation, enthusiasm, teamwork, and problem solving, is required.
  • Willingness to learn, teach, and grow in a fast-paced environment is required.
  • Industry experience, strong management skills, and basic knowledge of drug development processes are required.

Responsibilities

  • Oversee the development of novel lipid nanoparticle compositions.
  • Improve existing lipid nanoparticle formulations.
  • Manage the company's lipid nanoparticle team.
  • Advance targeted lipid nanoparticle delivery with novel approaches for in situ mRNA delivery.
  • Oversee physicochemical characterization of lipid nanoparticle formulations.
  • Work closely with internal teams and external collaborators and ensure delivery on key milestones.
  • Guide the company's RNA delivery strategy, particularly intellectual property and key deliverables.
  • Stay current with RNA delivery literature and prepare technical reports and white papers.
  • Prepare technical documents and manuscripts for regulatory filings, intellectual property prosecution, and publications.
  • Present scientific findings internally and externally at scientific conferences and industry events.

Desired Qualifications

  • Proficiency in the design and characterization of novel lipids is a plus.

About the Company

Kernal Biologics

Develops onco-selective mRNA therapeutics

Kernal Biologics develops mRNA therapies that target cancer cells and infectious diseases like COVID-19. It uses a proprietary platform that combines synthetic biology and deep learning to design mRNA molecules that avoid triggering RNA-sensing pathways and to enable therapeutic protein expression in specific cell types. The product works by delivering engineered mRNA into target cells, where it instructs them to produce a therapeutic protein with restricted expression to reduce side effects. The company differentiates itself through onco-selectivity, its data-driven design process, and partnerships with healthcare providers, research institutions, and pharmaceutical companies. Revenue comes from collaborations, grants, and sales of its mRNA platforms and therapies. The goal is to provide effective, tolerable, and affordable mRNA medicines by advancing targeted, cell-specific therapies for cancer and infectious diseases.

Company size
11-50
Company stage
Series A
Total funding
$26.8M
Headquarters
Cambridge, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Kernal Biologics

See more jobs